Moreover, we have demonstrated that stimulation of Tsp-1 via ectopic expression of PSAP and systemic delivery of a therapeutic peptide derived from PSAP potently inhibits primary and metastatic tumor growth in multiple tumor models4,5,16. This evidence concerns the gene PSAP and metastatic neoplasm.